Unknown

Dataset Information

0

A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management.


ABSTRACT: OBJECTIVES:The 21-gene assay Oncotype DX (21-GA) shows promise as a guide in deciding when to initiate adjuvant chemotherapy in women with hormone receptor-positive early-stage breast cancer. Nevertheless, its routine use remains controversial, owing to insufficient evidence of its clinical utility and cost-effectiveness. Accordingly, we aim to quantify the value of conducting further research to reduce decision uncertainty in the use of the 21-GA. METHODS:Using value of information methods, we first generated probability distributions of survival and costs for decision making with and without the 21-GA alongside traditional risk prediction. These served as the input to a comparison of 3 alternative study designs: a retrospective observational study to update risk classification from the 21-GA, a prospective observational study to estimate prevalence of chemotherapy use, and a randomized controlled trial (RCT) of the 21-GA predictive value. RESULTS:We found that current evidence strongly supports the use of the 21-GA in intermediate- and high-risk women. Further research should focus on low-risk women, among whom the cost-effectiveness findings remained equivocal. For this population, we identified a high value of reducing uncertainty in the 21-GA use for all proposed research studies. The RCT had the greatest potential to efficiently reduce the likelihood of choosing a suboptimal strategy, providing a value between $162 million and $1.1 billion at willingness-to-pay thresholds of $150?000 to $200?000/quality-adjusted life years. CONCLUSION:Future research to inform 21-GA decision making is of high value. The RCT of the 21-GA predictive value has the greatest potential to efficiently reduce decision uncertainty around 21-GA use in women with low-risk early-stage breast cancer.

SUBMITTER: Kunst NR 

PROVIDER: S-EPMC7343670 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management.

Kunst Natalia R NR   Alarid-Escudero Fernando F   Paltiel A David AD   Wang Shi-Yi SY  

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20190807 10


<h4>Objectives</h4>The 21-gene assay Oncotype DX (21-GA) shows promise as a guide in deciding when to initiate adjuvant chemotherapy in women with hormone receptor-positive early-stage breast cancer. Nevertheless, its routine use remains controversial, owing to insufficient evidence of its clinical utility and cost-effectiveness. Accordingly, we aim to quantify the value of conducting further research to reduce decision uncertainty in the use of the 21-GA.<h4>Methods</h4>Using value of informati  ...[more]

Similar Datasets

| S-EPMC6821112 | biostudies-literature
| S-EPMC4701034 | biostudies-literature
| S-EPMC6172658 | biostudies-literature
| S-EPMC9096864 | biostudies-literature
| S-EPMC9114034 | biostudies-literature
| S-EPMC5095927 | biostudies-literature
| S-EPMC5568788 | biostudies-literature
| S-EPMC9758791 | biostudies-literature
| S-EPMC9742556 | biostudies-literature
| S-EPMC3058239 | biostudies-literature